Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Risk Adjustment To Be Based On FEHBP Data Through 2009

Executive Summary

The Centers for Medicare & Medicaid Services expects prescription drug risk adjustments for Medicare Part D plans to be based on Blue Shield Federal Employees Health Benefits Program data until the end of 2009

You may also be interested in...



Risky Business? CMS Refining Medicare Rx Risk Adjustment Formula

The Medicare Rx risk-adjustment formula is likely to include a factor to increase payments for plans that enroll a larger percentage of low-income beneficiaries in the new outpatient drug benefit, Centers for Medicare & Medicaid Services Administrator Mark McClellan said during a Dec. 20 "open door" forum

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel